BridgeMD
New treatment option for Bariatric Surgery
Official title Protein Supplementation and Resistance Training to Prevent Fat-Free Mass Loss Following Metabolic-Bariatric Surgery
ClinicalTrials.gov ID: NCT07156552
What this study is testing
- What it's testing
- The goal of this clinical trial is to investigate the effects of daily protein supplementation and participation in a weekly supervised resistance training program on the prevention of excessive muscle mass loss following bariatric surgery. Patients treated at one of the participating centers will be invited to participate and will be randomly assigned to one of two groups.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- A scheduled metabolic-bariatric surgery (i.e. RYGB or Sleeve Gastrectomy)
- Participation in the NOK care program
- Able to understand and perform the study procedures
You likely can't join if
- Allergic or sensitive for milk proteins, or lactose intolerant
- Diagnosed renal insufficiency
- Diagnosed intestinal diseases influencing the uptake of protein (i.e. active inflammatory bowel disease
The study team makes the final eligibility decision.
Where it's taking place
- Amsterdam, Netherlands
- Nieuwegein, Netherlands
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Amsterdam, Netherlands; Nieuwegein, Netherlands. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.